How patients deal with an ambiguous medical test: Decision-making after genetic testing.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 33214013.
- Also identified by DOI 10.1016/j.pec.2020.10.020 and PMC identifier 12959046.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We know little about how patients make decisions when they receive a variant of uncertain significance result (VUS) from genetic testing. The purpose of this study was to elucidate a model of patient-informed decision-making after receiving a VUS result. Using an adapted Mental Models Approach, we conducted semi-structured interviews with women who received a VUS result from genetic testing for hereditary breast cancer (N = 20) to explore factors they believed were relevant to their decision-making. Two coders used a coding scheme informed by experts in hereditary breast cancer to conduct analysis. Inter-coder reliability was α = .86. Three overarching decision themes emerged from the interviews: managing ambiguity, medical risk management, and sharing results with others. While participants noted some difficulty understanding their result, genetic counselors' interpretations, psychosocial factors (e.g., risk perceptions), and competing extrinsic demands influenced their decisions. Complex influences affect patient decision-making after a VUS result from genetic testing and may encourage health protective behavior. Even patients who understand their test result could use support managing the ambiguity of their test result and sharing it with others.
Medical subject headings
- Breast Neoplasms
- Decision Making
- Genetic Testing